Clinical trial
Comparative Effectiveness of Oral Semaglutide vs Sitagliptin Among Individuals With Heart Failure With Preserved Ejection Fraction (STEP-HFpEF DM ORAL)
NCT07390110
Study timeline
Study start (actual)2026-01-24Date precision: day
Registry last updated2026-09-21
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type 2 Diabetesunresolved
Heart Failureunresolved
Interventions
Oral semaglutideDRUG
SitagliptinDRUG · verified · RxNorm: sitagliptin
Sponsors & collaborators
Brigham and Women's Hospitallead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07390110 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.